Investor profile
Jonathan Milner has backed 10 European tech companies across 13 funding rounds between 2017 and 2026, joining rounds totalling €231M. Most active in Healthtech and Software. Data as of 6 Aug 2026.
Also recorded as: Jonathan Milner.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Nuclera | UK | 3 | €94M |
| Relation Therapeutics | UK | 2 | €56M |
| PhoreMost | UK | 1 | €39M |
| SolasCure | UK | 1 | €12M |
| NanoSyrinx | UK | 1 |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Nuclera | Series A | €69M | 2024-10 |
| PhoreMost | Series B | €39M | 2024-09 |
| Relation Therapeutics | Seed | €32M | 2024-03 |
| Relation Therapeutics |
| €7.2M |
| PharmEnable | UK | 1 | €6.9M |
| Pencil Biosciences | UK | 1 | €6.5M |
| Clustermarket | UK | 1 | €2.9M |
| Repositive | UK | 1 | €2.9M |
| Spirea | UK | 1 | €2.9M |
| Seed |
| €24M |
| 2022-06 |
| Nuclera | Series B | €15M | 2022-07 |
| SolasCure | Series B | €12M | 2023-03 |
| Nuclera | Series C | €10M | 2026-01 |
| NanoSyrinx | Seed | €7.2M | 2021-07 |
| PharmEnable | Seed | €6.9M | 2023-05 |
| Pencil Biosciences | Seed | €6.5M | 2023-09 |
